TMCITREACE MEDICAL CONCEPTS, INC.同业对比
TREACE MEDICAL CONCEPTS, INC. 与SIC 3841 行业的逐项对比:市值、估值、增长、盈利能力、质量与总回报,以及在同业组内的排名。所有数值均由引擎从 SEC 申报与延迟行情计算,排名仅为组内排序位置 —— 描述性数据,非投资建议。
完整同业对比
同业组:同 SIC 行业分类 | 公司 | 市值 | 市盈率(TTM) | 市净率 | 市销率 | 营收同比增长 | 净利同比增长 | 息税前利润率 | 净资产收益率 | 投入资本回报率 | 皮氏 F 值 | 一年总回报 | 股息率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TMCI本股 | $296M#8 | — | 4.4x#9 | 1.4x#3 | 1.6%#10 | -5.8%#10 | -25.5%#9 | -87.1%#11 | -47.4%#10 | 2#11 | — | — |
| CLPT | $409M#1 | — | 37.9x#13 | 11.1x#15 | 17.8%#5 | -35.0%#13 | -65.4%#14 | -237.0%#13 | — | — | 25.9%#3 | — |
| SI | $373M#2 | 0.1x#1 | 3.0x#6 | 7.9x#12 | 49.6%#4 | -158.4%#14 | -55.6%#11 | -32.5%#9 | -22.9%#7 | 3#9 | 14.7%#5 | — |
| CTSO | $360M#5 | — | — | 9.7x#13 | 4.1%#8 | 60.4%#4 | -39.8%#10 | — | -122.1%#12 | 4#7 | — | — |
| OBIO | $362M#4 | — | 3.6x#7 | 10.8x#14 | 1169.2%#1 | 13.6%#8 | -154.7%#15 | -52.8%#10 | -54.9%#11 | — | 151.1%#1 | 5.5%#2 |
| OFIX | $363M#3 | — | 0.8x#2 | 0.4x#2 | 2.9%#9 | 26.8%#6 | -9.9%#7 | -21.5%#7 | -14.9%#6 | 5#4 | -39.9%#8 | — |
| MOBI | $359M#6 | — | 2.1x#5 | — | — | — | — | 0.0%#5 | — | — | — | — |
| TLSI | $303M#7 | — | 46.3x#14 | 6.7x#11 | 53.4%#3 | -30.6%#12 | -59.7%#12 | -598.9%#14 | — | 5#4 | 3.7%#7 | — |
| EMBC | $291M#9 | 3.5x#2 | — | 0.3x#1 | -3.8%#11 | 21.8%#7 | 22.4%#2 | — | 27.0%#1 | 6#3 | — | 12.0%#1 |
| ANIK | $279M#10 | — | 2.0x#4 | 2.5x#7 | -5.9%#13 | 80.4%#3 | -9.8%#6 | -8.0%#6 | -8.8%#5 | 4#7 | 141.0%#2 | — |
| INFU | $248M#11 | 31.2x#6 | 4.2x#8 | 1.7x#5 | 6.4%#7 | 182.6%#2 | 8.3%#5 | 11.2%#3 | 9.5%#4 | 9#1 | — | — |
| IDXG | $240M#13 | 9.9x#3 | 10.3x#11 | 6.2x#10 | -17.5%#14 | 267.2%#1 | 10.5%#4 | 105.8%#1 | 14.2%#3 | 5#4 | — | — |
| OSUR | $241M#12 | — | 0.8x#1 | 2.1x#6 | -38.1%#15 | -252.5%#15 | -62.6%#13 | -21.6%#8 | -43.8%#8 | — | 8.4%#6 | — |
| UTMD | $236M#14 | 22.6x#5 | 1.9x#3 | 6.1x#9 | -5.8%#12 | -18.7%#11 | 29.6%#1 | 9.2%#4 | — | — | 20.6%#4 | 1.7%#3 |
| PDEX | $228M#15 | 17.3x#4 | 4.8x#10 | 2.9x#8 | 16.5%#6 | 52.2%#5 | 16.8%#3 | 28.7%#2 | 17.3%#2 | 7#2 | — | — |
| STIM | $212M#16 | — | 11.9x#12 | 1.4x#4 | 99.2%#2 | 10.8%#9 | -21.1%#8 | -218.5%#12 | -43.9%#9 | 3#9 | — | — |
数值来自 SEC 申报与延迟行情;排名仅为该组内的排序位置 —— 描述性数据,不构成评级或建议。 本表构建超时,仅覆盖该组的一部分成员;排名仅相对于已列出的行,稍后会自动补全。 数据构建于 2026-09-16。
数据来自 SEC XBRL 申报与延迟行情 · 排名为组内排序 · 仅供参考 · 非投资建议